Global Arousal disorder treatment Market, Type (Arousal Disorder, Penetration Disorder, Female Orgasmic Disorder), Treatment (Hormone Therapy, Changing Medication Dosage), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Arousal Disorder Treatment Market Analysis and Size
The arousal disorder treatment market is expected to witness significant growth during the forecast period. Attributable to the extensive adoption of unhealthy lifestyles results in hormonal imbalance, which further results in arousal disorder. Psychological or physical conditions such as heart attacks and neurological diseases are the main reasons behind the arousal disorder. Additionally, conditions such as hormonal imbalance, renal failure, liver disorder, diabetes, substance addiction, alcoholism and others also lead to arousal disorder.
Data Bridge Market Research analyses a growth rate in the arousal disorder treatment market in the forecast period 2023-2030. The expected CAGR of arousal disorder treatment market is tend to be around 5% in the mentioned forecast period. The market was valued at USD 7.5 billion in 2022, and it would grow upto USD 11.08 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Arousal Disorder Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Arousal Disorder, Penetration Disorder, Female Orgasmic Disorder), Treatment (Hormone Therapy, Changing Medication Dosage), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Merck & Co., Inc. (U.S.), Cipla Inc. (U.S.), Novo Nordisk India Pvt Ltd (India), Sprout Pharmaceuticals, Inc (U.S.), Emotional Brain B.V. (Netherlands), Duchesnay Inc (Canada), Covis Pharma GmbH (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Female sexual arousal disorder occurs when the body is not responding to sexual stimulation. Doctors observed this differently from the hypoactive condition of sexual appetite, which has to do with a lack of desire for sexual activity. Erectile dysfunction is caused by two main factors such as physiological causes such as high blood pressure, obesity, diabetes, high cholesterol, smoking or tobacco use, and psychological causes such as stress, depression, mental health issues, etc.
Global Arousal Disorder Treatment Market Dynamics
Drivers
- Growing Awareness of Healthcare Infrastructure
A significant factor inducing the growth rate of global arousal disorder treatment market is the rising healthcare expenditure that helps in improving its infrastructure. Moreover, numerous government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.
- Rising Demand for Oral Drugs
Oral drugs is projected to prompt the market growth. The segment is estimated to boost the market as most products are available in capsule and tablet form and it is a very suitable route of administration.
Opportunities
- Growing Demand for Retail Pharmacies
The increase in the number of arousal disorder treatment delivered through several retail pharmacies and also the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.
Restraints/Challenges
- Risk of Side-Effects
The varied side-effects associated with arousal disorder treatment could limit the growth of the global arousal disorder treatment market over a forecast period. Side-effects such as headache to a lesser extent, low-back pain, anxiety, and irritation are visible with the use of arousal disorder treatment.
- High Cost
The huge expenditure associated with these agents hamper the market growth. Several hormonal therapies, that are somewhat necessary for fast recovery but gets unaffordable to many of the patients due to its high cost are hampering the growth of the market.
This arousal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the arousal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Arousal Disorder Treatment Market Scope
The arousal disorder treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Arousal Disorder
- Penetration Disorder
- Female Orgasmic Disorder
Treatment
- Hormone Therapy
- Changing Medication Dosage
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Arousal Disorder Treatment Market Regional Analysis/Insights
The arousal disorder treatment market is analyzed and market size insights and trends are provided by type, treatment, distribution channel and end-user as referenced above.
The major countries covered in the arousal disorder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for arousal disorder treatment market throughout the forecasted period due to rising awareness about sexual diseases, and the availability of treatment facilities, especially in developing nations such as China and India.
North America dominates the market due to the presence of key product manufacturers, high research and development, healthcare expenditure, and skilled professionals.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Arousal Disorder Treatment Market Share Analysis
The arousal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to arousal disorder treatment market
Key players operating in the arousal disorder treatment market include:
- Merck & Co., Inc. (U.S.)
- Cipla Inc. (U.S.)
- Novo Nordisk India Pvt Ltd (India)
- Sprout Pharmaceuticals, Inc (U.S.)
- Emotional Brain B.V. (Netherlands)
- Duchesnay Inc (Canada)
- Covis Pharma GmbH (U.S.)
SKU-